Sign inJoin waitlistJoin the waitlist

Kerri Becktell

Oncology Program Director · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · ·

History

Oncology · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Oncology · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Children's Wisconsin - Fox Valley
Present

Pediatric Hematology Oncology
Medical College of Wisconsin - Milwaukee
2016–2019
Pediatrics
McGaw Medical Center of Northwestern University
2013–2016
Michigan State University College of Human Medicine
2009–2013

Research

A View from the past into our collective future: the oncofertility consortium vision statement
Journal of Assisted Reproduction and Genetics · 2021 · 47 citations
Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes
Review · Clinical Cancer Research · 2024 · 42 citations
Inflammatory myofibroblastic tumor: A multi-institutional study from the Pediatric Surgical Oncology Research Collaborative
International Journal of Cancer · 2022 · 23 citations

Garrett Brodeur
6 papers
Lisa States
6 papers
Rachel Phelan
6 papers
Surya Rednam
6 papers
Lisa Diller
5 papers
Junne Kamihara
4 papers
EW
Elysa Widjaja
3 papers
Gail Tomlinson
3 papers
Jack Brzezinski
3 papers
JW
Jonathan Wasserman
3 papers
Nicole Liberio
3 papers · 1 as a fellow
Suzanne MacFarland
3 papers

Clinical trials

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2022–2028
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030